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Abstract: Beurteilung von Grösse und Funktion des linken Ventrikels beim Pferd mittels ‚anatomical M-
mode’ Echokardiographie Patrizia A. Grenacher, Colin C. Schwarzwald, 2010 Departement für Pferde,
Vetsuisse-Fakultät, Universität Zürich Ziele – Untersuchung der Anwendbarkeit und Reproduzierbarkeit
des ‚anatomical M-mode‘ (AMM) zur Beurteilung von Grösse und Funktion des linken Ventrikels (LV)
beim Pferd, Ermittlung der Übereinstimmung zwischen AMM und konventionellem ‚M-mode‘ (CMM)
sowie Erstellung von Referenzwerten. Tiere - 98 Pferde (Alter 13.1 ± 5.6 Jahre; Gewicht 538 ± 78 kg).
Methoden – Zweidimensionale und M-mode Aufnahmen wurden retrospektiv ausgewertet. Standardmes-
sungen der Grösse und Indizes der Funktion des LV, inklusive systolische Zeitintervalle, wurden im CMM
gemessen und mit AMM Messungen in Längsachsen- (lx) und Kurzachsenansicht (sx) verglichen. Ergeb-
nisse – Der Prozentsatz der messbaren Zyklen lag bei 99%, 97% und 90% für Routinemessungen des LV
im CMMsx, AMMsx und AMMlx Modus. Die systolischen Zeitintervalle konnten im AMM in ￿ 93% der
Zyklen gemessen werden, während das Maximum im CMM bei 77% lag. Die Übereinstimmung zwischen
AMMsx und CMMsx war sehr gut, die Übereinstimmung zwischen AMMlx und CMMsx war deutlich
schlechter. Die ‚Ejection time‘ des LV und die Dauer der elektromechanischen Systole zeigten eine hohe
Übereinstimmung zwischen den Methoden, die LV ‚Pre-ejection period‘ und der ‚Index of myocardial
performance‘ hingegen nicht. Die intra-observer und die inter-observer Variabilität waren für die meisten
Messwerte gering. Schlussfolgerungen – Der AMM kann anstelle des CMM für die Beurteilung der Grösse
des LV beim Pferd verwendet werden. Für die Bestimmung von Zeitintervallen wird der AMM jedoch
nicht empfohlen. Assessment of left ventricular size and function in horses using anatomical M-mode
echocardiography Patrizia A. Grenacher, Colin C. Schwarzwald, 2010 Equine Department, Vetsuisse Fac-
ulty, University of Zurich Objectives – To study the applicability of anatomical M-mode (AMM) for
assessment of left ventricular (LV) size and function in horses, evaluate agreement with conventional M-
mode (CMM), determine reliability, and establish reference intervals for AMM measurements. Animals
– 98 horses; 13.1 ± 5.6 years; 538 ± 78 kg. Methods – Two-dimensional and M-mode recordings were
analyzed retrospectively. Standard LV dimensions and indices of LV function, including time intervals,
were measured in CMM and compared with AMM studies in long-axis (lx) and short-axis (sx) views. Re-
sults – The percentages of measureable cycles were 99%, 97%, and 90% for routine LV studies in CMMsx,
AMMsx, and AMMlx mode. For time intervals, ￿ 93% of cycles could be measured using AMM compared
to a maximum of 77% using CMM. AMMsx measurements agreed well with CMMsx measurements for
LV studies; the agreement of AMMlx with CMMsx was markedly lower. The LV ejection time and the
duration of electro-mechanical systole, but not the LV pre-ejection period and the index of myocardial
performance, showed fair agreement between methods. Intraobserver and interobserver measurement
variabilities were low for most variables. Conclusions – AMM can replace CMM for assessment of LV
dimensions in horses, but is not recommended for measurement of time intervals.
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Abstract Objective: To study the applicability of anatomical M-mode (AMM) for
assessment of left ventricular (LV) size and function in horses, evaluate agreement
with conventional M-mode (CMM), determine reliability, and establish reference
intervals for AMM measurements.
Animals: 98 horses; 13.1  5.6 years; 538  78 kg.
Methods: Two-dimensional and M-mode recordings were analyzed retrospectively.
Standard LV dimensions and indices of LV function, including time intervals, were
measured in CMM and compared with AMM studies in long-axis (lx) and short-axis
(sx) views.
Results: The percentages of measureable cycles were 99%, 97%, and 90% for routine
LV studies in CMMsx, AMMsx, and AMMlx mode. For time intervals,  93% of cycles
could be measured using AMM compared to a maximum of 77% using CMM. AMMsx
measurements agreed well with CMMsx measurements for LV studies; the agreement
of AMMlx with CMMsx was markedly lower. The LV ejection time and the duration of
electromechanical systole, but not the LV pre-ejection period and the index of
myocardial performance, showed fair agreement between methods. Intraobserver
and interobserver measurement variabilities were low for most variables.
Conclusions: AMM can replace CMM for assessment of LV dimensions in horses, but is
not recommended for measurement of time intervals.
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Introduction
Echocardiography is a standard diagnostic proce-
dure and an important part of clinical and exper-
imental cardiac examinations in horses.
Nevertheless, the echocardiographic assessment
of left ventricular (LV) size and function is still
a demanding challenge for veterinary cardiologists
and is limited by a variety of technical, anatom-
ical, and physiological issues. Conventional M-
mode echocardiography (CMM) is widely used in
current clinical practice for assessing LV size and
function. Standard M-mode indices of LV size
include the internal diameter of the LV cavity
(LVID) and the thickness of the interventricular
septum (IVS) and the LV free wall (LVPW),
respectively. The LV fractional shortening (FS) and
the LV internal diameter at peak systole, respec-
tively, are the most commonly used M-mode-
derived indices of LV systolic function. Other
indices of LV function include systolic time inter-
vals (pre-ejection period, PEP; ejection time, ET;
and PEP/ET ratio) and the index of myocardial
performance (IMP, also referred to as Tei-
index).1e6
All of the above indices are routinely measured
or calculated from M-mode recordings obtained
from right parasternal short-axis views or occa-
sionally from long-axis views.1 The advantage of
the CMM technique is the high pulse repetition
frequency (200e1000 Hz), resulting in a high
temporal resolution (1e5 msec) that allows accu-
rate measurement of time intervals. The major
limitation of CMM is that the cursor line can only be
rotated around the apex of the imaging sector.7 To
achieve the exact orientation, CMM studies are
typically guided by reference to a simultaneously
obtained two-dimensional (2D) image. However,
ideal alignment is not always possible because of
individual thorax conformation, interference from
lung or ribs, or a limited cardiothoracic window.8
Furthermore, CMM does not allow tracking of
valve motion during the cardiac cycle. Therefore,
identification of onset and end of valve motion and
measurement of time events by CMM is often
difficult.
With advances in ultrasound technology such as
high-frame rate 2D imaging, expanded digital cine
memory, and powerful computer processing algo-
rithms, it has become possible to develop a modi-
fied M-mode method that can overcome some of
the limitations of CMM echocardiography.8 The so
called ‘anatomical M-mode’ (AMM)c can be applied
directly during the echocardiographic examination
(‘live’ AMM) or it can be used as a post-processing
technique that creates M-mode studies from digi-
tally stored 2D cine-loops. It allows the operator to
position the M-mode cursor freely on the 2D image,
independent of the sector apex. This technique
also allows rendering M-mode studies from
multiple orientations and updating the position of
the M-mode cursor between measurements.
Therefore, moving structures can be tracked
during the cardiac cycle and identification of time
events (i.e., valve opening and closure) is facili-
tated.7,9 With AMM it is possible to reduce the
duration of the echocardiographic examination,
because AMM tracings can be derived offline from
standard 2D recordings and can replace CMM
studies that have to be conducted ‘live’. The
contras of AMM are related to the relatively low
recording frame rate of 2D echocardiography
(approximately 50 frames per second in horses),
resulting in a relatively low temporal resolution
(approximately 20 ms).7e9 The ability to accu-
rately and reliably measure time intervals on AMM
recordings may therefore be limited.
The aim of this study was to investigate the
applicability and the reliability of the AMM for
assessment of LV size and function in horses and to
evaluate the agreement of AMM with CMM
measurements. We hypothesized that indices of LV
size and function by AMM can be reliably obtained
and are in good agreement with CMM indices. In
addition, the study aimed at establishing refer-
ence intervals for indices of LV size and function
measured with AMM in healthy horses.
Animals, materials and methods
Animals
The study population was chosen retrospectively
and included horses that underwent an echocar-
diographic examination at The Ohio State Univer-
sity or at The University of Zurich between January
2005 and March 2009. Enrollment criteria were
body weight > 300 kg, age > 2 years, and the
availability of a complete, standardized echocar-
diogram of good quality, with an ECG recorded
simultaneously and performed by a single operator
(CCS) on a digital echocardiography systemd.
Ninety-eight horses (31 females, 67 geldings) with
an age of 13.1  5.6 years (n ¼ 97) and a body
weight of 538  78 kg (n ¼ 87) fulfilled the
c EchoPAC Software v6.1.2, GE Medical Systems, Milwaukee,
WI.
d GE Vivid 7 ultrasound system, GE Medical Systems, Milwau-
kee, WI.
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inclusion criteria. The study population included
49 Warmblood horses, 20 Standardbreds, 13 Thor-
oughbreds, 6 Arabians, 2 Icelandic horses, 2
Quarter horses, and 1 each of the following
breeds: Haflinger, Freiberger, Paint, Cob, and Paso
Fino; in 1 horse breed was not reported. All
animals received adequate human care and were
treated during the examination according to the
ethical guidelines of the universities.
Of these horses, 78 were in normal sinus rhythm
(NSR) and 20 were in atrial fibrillation (AF). In the
NSR group, 42 horses had a structurally and func-
tionally normal heart. The remaining 36 horses had
structural or functional abnormalities as detected
by echocardiography. Grading of severity of
valvular regurgitation was achieved using a scoring
system based on the duration of the regurgitant
signal, high-velocity jet area and flow disturbance,
regurgitant signal duration, and the number of
imaging planes in which the high-velocity jet could
be observed in the receiving chamber.10 The
following abnormalities were diagnosed: Mild
mitral regurgitation (MR) (n ¼ 6), moderate MR
(n ¼ 6), severe MR (n ¼ 2), mild aortic regurgita-
tion (AR) (n ¼ 4), moderate AR (n ¼ 3), severe AR
(n ¼ 2), moderate tricuspid regurgitation (TR)
(n ¼ 1), mild MR & mild AR (n ¼ 2), mild MR &
moderate AR (n ¼ 2), mild MR & severe AR (n ¼ 1),
moderate MR & mild AR (n ¼ 1), moderate MR &
severe AR (n ¼ 1), moderate MR & moderate TR
(n ¼ 1), mild AR & mild pulmonic regurgitation (PR)
(n ¼ 2), congestive heart failure with moderate MR
& severe AR & moderate-to-severe TR & mild PR
(n ¼ 1), and congestive heart failure due to
myocarditis (n ¼ 1).
In the AF group, 5 horses had a structurally
normal heart as determined by echocardiography.
The remaining 15 horses had one of the following
diagnoses: Mild MR (n ¼ 1), mild AR (n ¼ 1), mild
TR (n ¼ 2), mild PR (n ¼ 2), mild MR & moderate AR
(n ¼ 1), severe MR & severe AR (n ¼ 1), moderate
MR & mild PR (n ¼ 1), mild MR & mild TR (n ¼ 1),
moderate MR & mild TR (n ¼ 1), mild AR & mild PR
(n ¼ 1), mild AR & mild TR (n ¼ 2), moderate MR &
moderate AR & moderate TR (n ¼ 1). Two of these
horses had signs of pulmonary hypertension
(maximum velocity of the tricuspid regurgitation
jet measured by spectral Doppler exceeded 3.5 m/
s) and 1 horse was in congestive heart failure.
Echocardiography
All horses underwent a complete echocardio-
graphic examination performed by a single oper-
ator (CCS) according to a standardized protocol.
During the examination, all horses were standing in
a quiet room and restrained by an experienced
handler. Three horses were sedated with 4 mg of
detomidinee intravenously prior to the examina-
tion, while the remaining 95 horses were not
sedated during the examination. Transthoracic 2D
echocardiography and 2D-guided CMM echocardi-
ography were performed using a high-end digital
echocardiographd with a phased array sector
transducerf working at frequencies from 1.5/3.1 to
1.9/4.0 MHz (octave harmonics). The median
frame rate for the 2D cine-loop recordings was
53.9 frames/s (fps), with a range of 28.9e71.1 fps.
Twenty-five echocardiograms were recorded at
frame rates below 50 fps. An ECG was recorded
simultaneously for timing of measurements within
the cardiac cycle.
All recordings were preformed in standard right-
parasternal imaging planes.1 The LV was imaged in
a long-axis (four-chamber) view in 2D mode and in
a short-axis view at the chordal level in 2D mode
and CMM. The mitral valve (MV) was imaged in
a four-chamber view in 2D mode and in a short-axis
view in 2D mode and CMM. The aortic valve (AoV)
was imaged in a long-axis view of the left
ventricular outflow tract (LVOT) in 2D mode and in
a short-axis view at the level of the valve in CMM.
In each imaging plane, at least 3 representative,
non-consecutive cardiac cycles were recorded in
horses with NSR and at least 5 cycles were recor-
ded in horses with AF. All images were stored
either as CMM still images or as 2D cine-loops in
digital raw-data format.
Anatomical M-mode analyses
All AMM analyses were performed offline by
a single observer (PAG) using the analysis software
of the echocardiography systemc. The AMM trac-
ings of the LV, the MV, and the AoV were generated
by positioning the electronic cursor through the
respective 2D cine-loop recordings. In LV short-axis
view, the AMM cursor was positioned through the
lumen of the LV, bisecting the interventricular
septum, the LV cavity, and the LV free wall into
two equal parts throughout the cardiac cycle
(Fig. 1). In LV long-axis view, the AMM cursor was
positioned at the chordal level, parallel to the MV
annulus (online-only Data Supplement Fig. I). For
analysis of MV motion, the AMM cursor was placed
across the MV leaflets in both the long-axis
recordings (parallel to the MV annulus) (Online-
only Data Supplement Fig. II) and in the short-axis
e Detomidine (Domosedan), Pfizer AG, Berlin, Germany.
f M3S and M4S phased array transducer, GE Medical Systems,
Milwaukee, WI.
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recordings of the valve (Fig. 2). For analysis of AoV
motion, the AMM cursor was placed across the AoV
leaflets (parallel to the AoV annulus) in the long-
axis recordings of the valve (Fig. 3). For correct
identification of MV and AoV opening and closure,
respectively, the AMM cursor was moved to follow
the valve leaflets during the cardiac cycle until the
opening and closure events were clearly delin-
eated. Where these time events were not clearly
visible using a single cursor position, two different
cursor positions were used at end-systole (AoV
closure, MV opening) and end-diastole (AoV
opening, MV closure). Anatomical M-mode was not
applied to short-axis recordings of the AoV,
because the available cine-loop recordings of the
AoV and the left atrium (LA) in short-axis had been
optimized for measurement of the LA but not for
assessment of AoV motion, and because preceding
pilot studies had shown that derived AMM tracings
rarely allowed proper identification of both AoV
opening and closure.
Measurements
All measurements were performed offline by
a single observer (PAG) using the digital raw-data
image files. The measurements were performed on
both the CMM and the AMM tracings. In horses with
NSR, we attempted to analyze 3 non-consecutive,
randomly chosen cardiac cycles for each imaging
plane and echocardiographic modality. Cycles
immediately following an incident of 2nd degree
atrio-ventricular block were excluded from anal-
yses. In horses with AF, we attempted to analyze 5
consecutive cycles, independent of the length of
the cycle. In horses, in which the available
recordings did not contain a sufficient number of
complete cardiac cycles for all imaging planes, all
available cycles were measured. On some record-
ings, unambiguous identification of anatomical
landmarks for measurements was not possible on
all cycles. In those cases, we measured only the
cycles, in which the landmarks could be clearly
identified. For each variable, the number of
available cycles and the number of measurable
cycles were noted. The heart rate (HR) of each
measured cycle was calculated based on the RR
interval preceding the analyzed cycle
(HR ¼ 60,000/RR).
For LV analyses, the ‘trailing-inner-inner-
leading’ edge method was used. End-diastolic
measurements of LV dimensions were timed to the
peak of the electrocardiographic R wave, because
the onset of the R wave was not always clearly
visible and the Q wave was usually absent in the
lead used. End-systolic measurements of LV
dimensions were made at the point of maximal
excursion of the interventricular septum and the
LV free wall. The following dimensions were
measured on the LV tracings: The interventricular
Figure 1 Anatomical M-mode image of the left
ventricle (LV), reconstructed from a digitally stored 2D
cine-loop recording obtained from a right parasternal
short-axis view at the chordal level. The AMM cursor line
(green) is positioned through the lumen of the LV,
bisecting the interventricular septum (IVS), the LV
cavity, and the LV free wall (LVPW) into two equal parts
throughout the cardiac cycle. An ECG is superimposed
for timing (For interpretation of the references to colour
in this figure legend, the reader is referred to the web
version of this article).
Figure 2 Anatomical M-mode image of mitral valve
motion, reconstructed from a digitally stored 2D cine-
loop recording obtained from a right parasternal short-
axis view at the level of the mitral valve. The AMM cursor
line (green) is placed across the MV leaflets. Notice that
in this example, both the time of mitral valve closure
(MVC) and the time of mitral valve opening (MVO) can be
identified on the same AMM tracing (For interpretation
of the references to colour in this figure legend, the
reader is referred to the web version of this article).
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septal thickness at end-diastole (IVSd) and at peak
systole (IVSs), the LV internal diameter at end-
diastole (LVIDd) and at peak systole (LVIDs), and
the LV free wall thickness at end-diastole (LVPWd)
and at peak systole (LVPWs). The LV fractional
shortening (FS, in %) was calculated as
FS ¼ (LVIDdLVIDs)/LVIDd  100. The LV mass
(in g) was calculated as LV mass ¼ 1.04 
[(LVIDd þ LVPWd þ IVSd)3LVIDd3]13.6.11e13 The
relative LV wall thickness at end-diastole (RWT)
was calculated as RWT ¼ (LVPWd þ IVSd)/LVIDd.
The mean LV wall thickness at end-diastole (MWT)
was calculated as MWT ¼ (LVPWd þ IVSd)/2.
On the MV tracings, the MV closure-to-opening
interval (MVCO) was measured as the time interval
from MV closure to MV opening (Fig. II) (Fig. 2).
On the AoV tracings, the LV pre-ejection period
(LVPEP) was measured as the time interval from
the peak of the echocardiographic R wave to the
opening of the AoV on the AoV tracing, and LV
ejection time (LVET) was measured as the time
interval from opening to closure of the AoV on the
same tracing (Fig. 3). The LVPEP/LVET ratio and
the duration of electromechanical systole
(EMS ¼ LVPEP þ LVET) were calculated.
For each measured variable, the average of the
realized measurements was calculated and used for
further analyses. With the averaged data, the
following compound indices (i.e., indices calculated
frommeasurementsmade indifferent imagingplanes
and in different cardiac cycles) were calculated: The
mean velocity of circumferential fiber shortening,
Vcf ¼ (LVIDdLVIDs)/(LVIDd  LVET); the rate-cor-
rected mean velocity of circumferential fiber short-
ening, Vcfc ¼ (LVIDdeLVIDs)/(LVIDd  (LVET/ORR));
and the index of myocardial performance (Tei-
Index), IMP ¼ (MVCOLVET)/LVET.
Measurement reliability
To determine the intraobserver and interobserver
measurement reliability, a subgroup of 5 randomly
selected horses was re-analyzed by the same
observer (PAG) and by a second observer (CCS).
The second analyses also included repeated
generation of AMM tracings from 2D cine-loops.
Both observers were blinded to signalment, diag-
nosis, previously measured cycles, and previous
measurements.
Data analysis and statistics
Graphical presentation, data analyses, and statis-
tics were performed using commercial computer
softwareg,h,i. For each variable and each echo-
cardiographic modality (i.e., CMM, AMM), the
percent ratio of measurable over available cardiac
cycles was calculated. For analysis of agreement
between CMM and AMM, measurements were only
included if the average HR differed by less than
25%. Data points for which HR differed by > 25%
between CMM and AMM were excluded from anal-
ysis, in order to reduce bias related to differences
in heart rate rather than differences in
Figure 3 Anatomical M-mode images of aortic valve motion, reconstructed from a digitally stored 2D cine-loop
recording obtained from a right parasternal long-axis view of the left ventricular outflow tract. The AMM cursor line is
placed across the AoV leaflets, parallel to the AoV annulus. Depending on the position of the cursor line, the time of
aortic valve opening (Fig. 3A, AVO) or aortic valve closure (Fig. 3B, AVC) can be identified. The ability to track aortic
valve motion by AMM greatly facilitates measuring the systolic time intervals compared to CMM imaging.
g Microsoft Office Excel 2008, Microsoft Corporation, Red-
mond, WA.
h GraphPad Prism v5.02 for Windows, GraphPad Software, San
Diego, CA.
i SigmaStat v3.5, SPSS Inc, Chicago, IL.
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echocardiographic modality. After averaging the
realized measurements (i.e., 3 measurements for
horses in NSR and 5 measurements for horses in
AF), method agreement was assessed using Bland-
Altman analyses. For each variable, mean bias and
95% limits of agreement were calculated and
reported as absolute values and as percent values.
The methodical details of Bland-Altman analyses
have been described elsewhere.14,15 Briefly, mean
bias is calculated as the mean difference between
the two methods and describes the average
discrepancy of measurements obtained using the
two methods. The 95% limits of agreement are
calculated as the mean bias plus or minus 1.96
times the standard deviation of the differences
between the two methods. For any variable, the
difference between measurements using the two
methods will lie within the limits of agreement in
95% of the time. Hence, bias and limits of agree-
ment are indices of comparability between two
methods that have to be interpreted in relation to
the magnitude of the respective variable. There-
fore, summary statistics (mean  SD) for each
variable were reported for comparison. Agreement
was further assessed using Lin’s concordance
correlation.16 Lin’s concordance was reported as
the sample concordance correlation coefficient
(rc) and its lower one-sided 95% confidence
limit.17,18 The coefficient ranges from 0 to 1 and
increases in value as a function of the nearness of
the data to the line of perfect concordance and
the tightness of the data about this axis. To our
knowledge, there is as yet no established
descriptive scale for the degree of agreement of
echocardiographic variables using rc. Accordingly,
rc was regarded as a complementary measure of
agreement that was used for comparison of the
different variables and echocardiographic modali-
ties within this study rather than as an absolute
measure of agreement.
To establish reference intervals for themeasured
and calculated variables, we used the data from
anamnestically and clinically healthy horses that
were in normal sinus rhythm and had a structurally
normal heart on echocardiographic examination.
The healthy population was classified by breed into
three groups: Warmbloods, Standardbreds and
Thoroughbreds. For each group, reference intervals
of each variable were reported with the 2.5%
percentile being the lower limit and the 97.5%
percentile being the upper limit of the interval.
Body weight was reported as mean  SD.
Intraobserver measurement reliability and
interobserver measurement reliability were quan-
tified by the within-subject variance for repeated
measurements (residual mean square) determined
by 1-way analysis of variance with the horses as
groups.19 The within-subject standard deviation
(sw)was calculated as the square root of the residual
mean square.Measurement variabilitywas reported
in 2 ways: (1) The within-subject coefficient of
variation (CV) expressed as a percent value was
calculated as CV ¼ sw/mean  100 in order to
compare the reliability of the various variables in
this study.19 The degree of variabilitywas arbitrarily
defined as follows: CV < 5%, very low variability;
5e15%, low variability; 16e25%, moderate vari-
ability;>25%, high variability. (2) In addition to the
CV, the absolute value below which the difference
between 2 measurements will lie with 95%
probability was estimated following the British
Standards Institution (BSI) recommendations:
BSI ¼ 1.96  O2  sw ¼ 2.77  sw.19 The BSI was
reported to provide a clinically applicable measure
of variability, hence an absolute value that allows
comparison with measured changes in echocardio-
graphic variables on a case-by-case basis.
Results
Table 1 summarizes the number of available
cardiac cycles and the number of measurable
cycles in the study population. The results show
that the percentage of measureable cycles was
comparable for LV studies performed in CMM in
short-axis views (CMMsx) and AMM in short-axis
views (AMMsx), and slightly lower for AMM in long-
axis views (AMMlx). For MV and AoV time intervals,
the percentage of measurable cycles was markedly
higher using AMM compared to CMM.
The results of the analyses of agreement are
summarized in Table A (online-only Data Supple-
ment). Generally, for the LV study, AMMsx measure-
ments agreed well with CMMsx measurements, while
the agreement of AMMlx measurements was mark-
edly lower, particularly for the septal thickness, the
Table 1 Ratio of measurable cardiac cycles over
available cardiac cycles for conventional M-mode
applied to short-axis imaging planes (CMMsx) and
anatomical M-mode applied to short-axis (AMMsx) and
long-axis (AMMlx) imaging planes.
LV study MVCO LVPEP, LVET
CMMsx 309/312 (99%) 237/307 (77%) 160/306 (52%)
AMMsx 255/263 (97%) 224/229 (98%) e
AMMlx 264/295 (90%) 285/299 (95%) 268/287 (93%)
LV study: Measurements of left ventricular dimensions (see
Table 2). MVCO: Mitral valve closure-to-opening interval.
LVPEP: Left ventricular pre-ejection period. LVET: Left
ventricular ejection time.
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Table 2 Reference intervals for CMM and AMM measurements in clinically healthy horses in normal sinus rhythm, reported as the interval between the 2.5% and
the 97.5% percentile.
Breed CMMsx AMMsx AMMlx
Warmbloods Standardbreds Thoroughbreds Warmbloods Standardbreds Thoroughbreds Warmbloods Standardbreds Thoroughbreds
BWT(kg) 550  59 539  31 548  59 550  59 539  31 548  59 550  59 539  31 548  59
LV HR (/min) 32e66
(n ¼ 13)
28e49
(n ¼ 15)
29e55
(n ¼ 7)
30e67
(n ¼ 13)
32e48
(n ¼ 9)
30e50
(n ¼ 4)
34e68
(n ¼ 11)
29e51
(n ¼ 9)
31e47
(n ¼ 5)
IVSd (cm) 2.7e3.8
(n ¼ 13)
2.5e3.8
(n ¼ 15)
3.0e3.7
(n ¼ 7)
2.7e3.5
(n ¼ 13)
2.9e3.5
(n ¼ 9)
2.9e3.8
(n ¼ 4)
2.1e3.0
(n ¼ 11)
1.8e3.0
(n ¼ 9)
2.0e3.2
(n ¼ 5)
LVIDd (cm) 9.9e12.9
(n ¼ 13)
10.2e13.2
(n ¼ 15)
10.9e13.6
(n ¼ 7)
10.1e13.3
(n ¼ 13)
10.0e13.7
(n ¼ 9)
10.9e12.9
(n ¼ 4)
10.7e12.6
(n ¼ 11)
11.0e14.3
(n ¼ 9)
11.6e12.6
(n ¼ 5)
LVPWd (cm) 1.9e2.9
(n ¼ 13)
1.7e3.1
(n ¼ 15)
2.2e2.7
(n ¼ 7)
1.8e3.2
(n ¼ 13)
1.7e2.9
(n ¼ 9)
2.3e2.9
(n ¼ 4)
1.9e2.5
(n ¼ 11)
1.8e3.6
(n ¼ 9)
2.0e2.6
(n ¼ 5)
IVSs (cm) 4.5e5.2
(n ¼ 13)
3.8e5.5
(n ¼ 15)
4e5.2
(n ¼ 7)
4.1e5.4
(n ¼ 13)
4.2e5.6
(n ¼ 9)
4.1e5.2
(n ¼ 4)
3.7e4.4
(n ¼ 11)
2.8e4.5
(n ¼ 9)
3.4e4.4
(n ¼ 5)
LVIDs (cm) 5.5e8.3
(n ¼ 13)
5.3e8.9
(n ¼ 15)
6.6e8.7
(n ¼ 7)
5.9e8.8
(n ¼ 13)
5.0e9.0
(n ¼ 9)
6.7e9.4
(n ¼ 4)
5.7e8.6
(n ¼ 11)
5.6e8.8
(n ¼ 9)
6.4e8.3
(n ¼ 5)
LVPWs (cm) 3.5e4.9
(n ¼ 13)
2.7e4.3
(n ¼ 15)
3.9e4.7
(n ¼ 7)
3.0e5.1
(n ¼ 13)
2.7e4.6
(n ¼ 9)
4e4.6
(n ¼ 4)
3.2e4.3
(n ¼ 11)
3.2e4.8
(n ¼ 9)
4.0e4.7
(n ¼ 5)
LV FS (%) 33e46
(n ¼ 13)
31e49
(n ¼ 15)
32e42
(n ¼ 7)
32e49
(n ¼ 13)
33e50
(n ¼ 9)
32e42
(n ¼ 4)
30e52
(n ¼ 11)
25e51
(n ¼ 9)
34e45
(n ¼ 5)
LV mass (g) 2482e4649
(n ¼ 13)
2100e5477
(n ¼ 15)
3262e4733
(n ¼ 7)
2598e5550
(n ¼ 13)
2410e5040
(n ¼ 9)
2197e5876
(n ¼ 4)
2253e3725
(n ¼ 11)
1890e4368
(n ¼ 9)
2594e3897
(n ¼ 5)
MWT (cm) 2.4e3.2
(n ¼ 13)
2.2e3.5
(n ¼ 15)
2.7e3.2
(n ¼ 7)
2.4e3.2
(n ¼ 13)
2.4e3.2
(n ¼ 9)
2.6e3.4
(n ¼ 4)
2.0e2.6
(n ¼ 11)
1.9e3.2
(n ¼ 9)
2.1e2.7
(n ¼ 5)
RWT 0.41e0.63
(n ¼ 13)
0.39e0.56
(n ¼ 15)
0.40e0.56
(n ¼ 7)
0.38e0.61
(n ¼ 13)
0.38e0.57
(n ¼ 9)
0.41e0.62
(n ¼ 4)
0.33e0.47
(n ¼ 11)
0.32e0.54
(n ¼ 9)
0.36e0.43
(n ¼ 5)
Vcf (circ/s) 0.66e1.03
(n ¼ 8)
0.57e0.90
(n ¼ 5)
0.64e0.86
(n ¼ 4)
0.70e1.03
(n ¼ 12)
0.73e1.07
(n ¼ 8)
0.79e0.83
(n ¼ 2)
0.67e1.13
(n ¼ 11)
0.62e1.18
(n ¼ 8)
0.78e1.04
(n ¼ 4)
Vcfc (circ/s) 0.83e1.19
(n ¼ 8)
0.75e1.04
(n ¼ 5)
0.84e1.14
(n ¼ 4)
0.88e1.31
(n ¼ 12)
0.92e1.30
(n ¼ 8)
0.98e1.03
(n ¼ 2)
0.88e1.26
(n ¼ 11)
0.68e1.40
(n ¼ 8)
0.96e1.33
(n ¼ 4)
MV HR (/min) 36e70
(n ¼ 12)
28e52
(n ¼ 11)
30e73
(n ¼ 6)
35e67
(n ¼ 12)
32e47
(n ¼ 5)
33e37
(n ¼ 3)
34e67
(n ¼ 12)
29e51
(n ¼ 10)
32e46
(n ¼ 5)
MVCO (ms) 441e673
(n ¼ 12)
516e671
(n ¼ 11)
361e769
(n ¼ 6)
450e706
(n ¼ 12)
543e684
(n ¼ 5)
547e599
(n ¼ 3)
457e736
(n ¼ 12)
525e692
(n ¼ 10)
608e643
(n ¼ 5)
IMP 0.13e0.40
(n ¼ 6)
0.01e0.49
(n ¼ 4)
0.06e0.43
(n ¼ 3)
0.18e0.49
(n ¼ 11)
0.19e0.62
(n ¼ 5)
0.24e0.37
(n ¼ 2)
0.20e0.53
(n ¼ 12)
0.15e0.46
(n ¼ 7)
0.30e0.48
(n ¼ 4)
AoV HR (/min) 30e68
(n ¼ 8)
29e46
(n ¼ 4)
34e44
(n ¼ 4)
34e64
(n ¼ 13)
29e50
(n ¼ 12)
32e58
(n ¼ 6)
LVPEP (ms) 37e61
(n ¼ 8)
50e110
(n ¼ 4)
52e104
(n ¼ 4)
47e94
(n ¼ 13)
52e99
(n ¼ 11)
52e86
(n ¼ 6)
LVET (ms) 388e532
(n ¼ 8)
386e547
(n ¼ 4)
458e538
(n ¼ 4)
381e488
(n ¼ 13)
397e483
(n ¼ 11)
370e488
(n ¼ 6)
LVPEP/LVET 0.07e0.13
(n ¼ 8)
0.10e0.29
(n ¼ 4)
0.10e0.23
(n ¼ 4)
0.11e0.20
(n ¼ 13)
0.12e0.21
(n ¼ 11)
0.14e0.18
(n ¼ 6)
EMS (ms) 440e588
(n ¼ 8)
497e614
(n ¼ 4)
562e600
(n ¼ 4)
429e573
(n ¼ 13)
477e582
(n ¼ 11)
421e575
(n ¼ 6)
BWT: Body weight (reported as mean  SD). For remainder of the key see text.
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free wall thickness, and the derived variables (i.e.,
LV mass, MWT, and RWT). Among the time intervals,
MVCO, LVET and EMS showed fair agreement
between CMMsx and AMM measurements, while
agreement of LVPEP was low. The calculated
compound indices (i.e., Vcf, Vcfc, and IMP) showed
markedly lower agreement than measured indices.
Agreement of the IMP was poor.
The reference intervals for all echocardio-
graphic variables for clinically healthy horses are
summarized in Table 2, grouped by echocardio-
graphic modality and breed.
Reliability data of all echocardiographic vari-
ables, grouped by echocardiographic modality, are
summarized in Table B (online-only Data Supple-
ment). Based on the CV, intraobserver measure-
ment variability and interobserver measurement
variability were very low to low for all variables,
with the exception of the IMP, showing low to
moderate variability. Overall, variability was lower
for CMMsx and AMMsx compared to AMMlx. Within
each echocardiographic modality, interobserver
measurement variability was generally slightly
higher than intraobserver measurement vari-
ability, but they were not substantially different
and were in a comparable range for all variables.
Discussion
The results of the current study indicate that AMM
is readily applicable to analyze digitized 2D cine-
loop recordings obtained from adult horses and
that, for most instances, is reliable and in good
agreement with routine CMM measurements of LV
size and LV function.
The AMM technique offers several advantages
over the CMM methodology. In clinical routine, the
most useful features of AMM are the ability to
generate AMM tracings offline, the free orientation
of the cursor line, and the tracking capabilities.7,9
The fact that AMM can be applied as a post-pro-
cessing feature allows reducing the time required
for acquiring echocardiographic recordings by
several minutes. This may be of particular interest
when examining animals that need to be physically
restrained during the examination. The possibility
to freely orientate the cursor line permits studying
any cardiac structure upon every angle of inter-
rogation. It allows anatomically consistent place-
ment of the cursor line, resulting in better
standardization of the examination and a higher
degree of accuracy and precision.8 The tracking
function allows to follow moving structures (e.g.,
valve leaflets) during cardiac cycle to optimize and
standardize cursor placement. Accordingly, we
were able to show that the AMM method facilitates
the measurement of MV and AoV time intervals,
with a higher percentage of measureable cycles
using the AMM technique. For the LV study, the
tracking feature is less critical and therefore was
not used in this study. Nonetheless, the
percentage of measureable cycles was only slightly
lower for AMM compared to CMM.
The quality of the stored 2D cine-loops of LV short-
axis planes in this study allowed generating high-
quality AMMsx tracings. For routine LV measure-
ments, the agreement of AMMsx with CMMsx and the
measurement reliability were considered suffi-
ciently high for use of AMM in clinical applications.
For LVmeasurements in AMMlx, the percentage of
measurable cycles, the agreement with CMMsx
measurements, and the measurement reliability
were lower than observed in AMMsx. This can be
explained by a variety of methodological and tech-
nical issues. In some recordings, generation ofAMMlx
tracings of the LV was hampered by inadequate
image quality of the stored 2D cine-loops, in which
the LV free wall could not be clearly identified.
Another difficulty in AMMlx tracingswas the covering
of the IVS by the tricuspid valve leaflet, impairing
the ability to clearly identify the right-ventricular
surface of the IVS. Because no measurements were
taken from cycles where the anatomical landmarks
(i.e., the endocardial and epicardial linings) could
not be clearly identified, this resulted in a slightly
lower percentage of measurable cycles in AMMlx
compared to AMMsx or CMMsx recordings.
Unlike AMMsx tracings, AMMlx tracings are
obtained in an imaging plane that differs from the
plane used for CMMsx recordings. Therefore,
although the same anatomical structures are
studied in AMMsx and AMMlx, placement of the cursor
line and the resulting measurements will inevitably
be different. In both short-axis and long-axis
imaging planes, translational motion of the heart
causes changes of the position of the cursor line
relative to the LV cavity, adds to measurement
error, anddecreasesmethodagreement. Consistent
placement of the AMM cursor in a LV long-axis view,
at the chordal level, parallel to the mitral valve
annulus, and without excessive interaction of the
mitral valve leaflets, is hindered by the base-to-
apex shortening effect of the LV during the cardiac
cycle. Furthermore, translational motion of the
heart can also result in changing orientation of the
imaging plane during the cardiac cycle, so that it
does not always cross the LV at its maximum
dimension. Obviously, translational motion and
base-to-apex shortening effect are also present
when recording 2D or CMM images in short-axis
planes. However, they are less obvious to the
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observer and may affect measurements to a lesser
degree, as long as the cursor line crosses the LVat its
widest dimension throughout the cardiac cycle. The
detailed investigation of the influence of trans-
lational motion and base-to-apex LV shortening on
the accuracy of AMMmeasurements was beyond the
scope of this study.
The results indicate that AMM facilitates
measurement of systolic time intervals by virtue of
its tracking function. Tracking allows following the
spatial position of the moving valves throughout
the cardiac cycle, making it easier to identify the
valve opening and the valve closure on the AMM
tracing. Conversely, CMM does not allow tracking
of moving structures and often does not depict
time events clear enough to allow accurate and
reliable measurement of time intervals. In this
study, MVCO, LVET, and EMS by AMM could be
measured reliably in over 90% of the cycles and
showed fair agreement with CMMsx measurements.
The reliability and agreement with CMM of LVPEP
and LVPEP/LVET by AMM were markedly lower,
most likely because of the relatively short duration
of the LVPEP, rendering it more susceptible to
measurement errors and influence of low temporal
resolution (see below). Therefore, the clinical use
of LVPEP and LVPEP/LVET by AMM analysis of aortic
valve motion is not recommended in horses.
Measurement of MVCO is primarily useful for
calculation of the IMP, which is an index of
combined systolic and diastolic myocardial perfor-
mance. However, mitral valve motion is not only
determined by LV myocardial function, but is also
influenced by LV end-diastolic pressure, aortic
insufficiency, and duration of the PQ interval,
resulting in premature or delayed mitral valve
closure.20 This may result in difficulties measuring
the MVCO and may indirectly impair the accuracy of
the IMP to represent myocardial performance.
Another problem when calculating the IMP using M-
mode measurements of MVCO and LVET is the fact
that time intervals are measured sequentially in
different imaging planes and in different cardiac
cycles. Consequently, the accuracy of the results
may be compromised by fluctuations in HR.5 To
minimize the effect of HR in this study, the differ-
ence in HR between AMM and CMM measurements
had to be less than 25%. Nonetheless, the IMP by
AMM showed inferior agreement with CMM
compared to other measurements and was charac-
terized by only moderate reliability. Therefore, we
suggest that derivation of the IMP from CMM or AMM
tracings should not be recommended in horses.
Measurement variability is relevant to the study
of method agreement because the measurement
errors inherent to the two methods being
compared limit the degree of agreement which is
possible.14 If one or both methods have high
measurement variability, the agreement between
the two methods will be poor as well. Hence,
comparison of the 95% limits of agreement
obtained from Bland-Altman analyses with the BSI
value obtained from variability analyses provides
additional information on the influences of
measurement error on method agreement.
Generally, the higher the BSI value is, the larger
the influence of measurement error on method
agreement will be. Overall, for LV measurements,
variability was low and method agreement was
high. Conversely, the measurement variability was
higher, and the method agreement lower, for
LVPEP, LEPEP/LVET, and IMP. For most instances,
the interobserver variability was only slightly
higher than the intraobserver variability, indi-
cating that the AMM method is relatively robust to
observer-related measurement errors.
The retrospective design of the study needs to
be listed as one of its limitations. However, the
fact that in both hospital locations one single
operator performed all echocardiographic record-
ings following a standardized protocol and using
the same type of digital ultrasound equipment
certainly minimized the error introduced due to
different recording techniques.
AMM studies are derived from 2D cine-loops and
therefore are affected by the limitations of 2D
echocardiography, namely lower resolution and
frame rates. The CMM studies benefit from high
pulse repetition frequency available for interroga-
tion. The pulse repetition frequency provides a high
degree of temporal and axial resolution that is ideal
for study of mobile cardiac structures. In this study,
25 echocardiograms were recorded at frame rates
below 50 fps, resulting in low temporal resolution (i.
e., >20 ms). This may particularly have influenced
agreement and reliability of the short-lasting LVPEP
and the related LVPEP/LVET ratio. However, the
majority of studies were recorded at frame rates
above 50 fps. Furthermore, 3 to 5 measurements
were averaged for each cycle, likely removing some
of the effects of measurement error due to low
temporal resolution. Nonetheless, as discussed
above, the results of this study suggest that AMM
may not be suitable for measurement of short-
lasting time events in horses.
Another limitation concerns the reference
intervals reported in this study. Reference inter-
vals were reported for all variables, even for those
where the number of available horses was very
low. However, reference intervals should ideally
be determined on populations larger than 50 to 100
individuals.21 Therefore, the intervals reported
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here must be interpreted with caution and should
be regarded as preliminary.
Conclusion
The present study shows that AMM is applicable for
assessment of LV size and function in horses. The
results suggest that AMMsx can replace CMMsx for
routine assessment of LV size and function, with
generally high method agreement and adequate
measurement reliability. However, it needs to be
recognized that AMM measurements largely
depend on the quality of the 2D cine-loop record-
ings that are used to generate the AMM tracings.
Therefore, the availability of high-end digital
echocardiography equipment is an important
prerequisite to produce high-quality AMM tracings
with adequately high frame rates. But even with
appropriate equipment, accurate measurement of
short-lasting time intervals is limited. Further-
more, M-mode measurements are limited to
a single dimension, disregarding the fact that the
heart is a complex three-dimensional structure.
Recent human imaging guidelines emphasize the
advantages of area-based and volume-based
indices for assessment of chamber dilation and
dysfunction, because linear measurements may be
somewhat insensitive, particularly in the presence
of non-uniform chamber enlargement, alterations
in chamber geometry, and presence of regional
wall motion abnormalities.22 Therefore, one can
argue that echocardiographic measurements
should be made directly within the 2D recordings
instead of using the derived AMM tracings. This
would offer the advantage that two-dimensional
area measurements and three-dimensional volume
estimates could be obtained. In fact, the use of M-
mode measurements may be regarded somewhat
antiquated and is largely based on traditional
conventions that were agreed on in times when the
quality of 2D echocardiograms was still hampered
by very low resolution and frame rates. However,
M-mode measurements are still widely used for
assessment of LV size and function in horses and
may actually be superior to 2D cine-loop record-
ings for subjective visual assessment of LV wall
motion patterns and LV systolic function. This
study was not aimed at comparing the use of linear
M-mode measurements with linear dimensions,
area measurements, or volume estimates obtained
from 2D echocardiograms. Therefore, further
studies will be needed to show if M-mode
measurements of LV size and function should still
be considered state-of-the-art in the age of high-
quality digital echocardiography.
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Table A: Analysis of agreement between CMM and AMM measurements.  
 
 
  CMMsx AMMsx AMMlx 
    Bland-Altman Analysis 
Lin`s Concordance 
Coefficient  Bland-Altman Analysis 
Lin`s Concordance 
Coefficient 
 Variable Mean ± SD Mean ± SD 
Bias 
(absolute) 
95% LA 
(absolute) 
Bias  
(%) 
95% LA 
(%) ρc 
Lower 95% 
CL Mean ± SD 
Bias 
(absolute) 
95% LA 
(absolute) 
Bias 
(%) 
95% LA 
(%) ρc 
Lower 95% 
CL 
L
V
 
HR (/min) 41 ± 10 41 ± 11 - 0.1 - 6.4 to 6.1 - 0.3 - 14.9 to 14.3 0.96 0.94 42 ± 10 0.7 - 10.0 to 11.5 1.7 - 23.2 to 26.7 0.85 0.80 
IVSd (cm) 3.1 ± 0.4 3.1 ± 0.4 - 0.04 - 0.54 to 0.45 - 1.3 - 17.3 to 14.6 0.81 0.74 2.4 ± 0.4 - 0.72 - 1.62 to 0.19 - 26.1 - 58.5 to 6.4 0.14 0.06 
LVIDd (cm) 12.0 ± 1.5 12.0 ± 1.6 0.03 - 0.94 to 0.99 0.3 - 7.9 to 8.4  0.95 0.93 12.1 ± 1.4 0.06 - 1.43 to 1.56 0.7 - 11.9 to 13.3 0.87 0.82 
LVPWd (cm) 2.5 ± 0.4 2.4 ± 0.4 - 0.05 - 0.68 to 0.58 - 2.3 - 28.3 to 23.6 0.71 0.62 2.3 ± 0.4 - 0.12 - 0.92 to 0.68 - 4.4 - 37.6 to 27.6 0.54 0.41 
IVSs (cm) 4.5 ± 0.5 4.6 ± 0.5 0.03 - 0.81 to 0.86 0.6 - 18.4 to 19.7 0.69 0.59 3.7 ± 0.8 - 0.81 - 2.34 to 0.71 - 20.8 - 55.5 to 13.9 0.20 0.10 
LVIDs (cm) 7.3 ± 1.1 7.3 ± 1.1 0.01 - 1.20 to 1.22 0.2 - 18.0 to 18.4 0.84 0.79 7.4 ± 1.3 0.04 - 1.78 to 1.86 0.1 - 25.0 to 25.2 0.72 0.62 
LVPWs (cm) 4.2 ± 0.6 4.2 ± 0.6 - 0.01 - 0.66 to 0.63 - 0.6 - 16.3 to 15.1 0.83 0.76 4.2 ± 0.6 - 0.18 - 1.26 to 0.91 - 4.8 - 35.5 to 26.0 0.57 0.45 
LV FS (%) 39 ± 6 39 ± 6 0.0 - 8.4 to 8.4 - 0.1 - 21.1 to 20.9 0.74 0.65 39 ± 6 0.3 - 13.7 to 14.4 0.9 - 36.0 to 37.9 0.36 0.19 
LV mass (g) 3938 ± 930 3857 ± 967 - 68.9 - 1033.0 to 895.1 - 2.0 - 27.8 to 23.7 0.86 0.81 3152 ± 790 -755.9 - 1805.0 to 293.0 - 21.4 - 49.5 to 6.9 0.59 0.50 
MWT (cm)  2.8 ± 0.3 2.8 ± 0.4 - 0.05 - 0.46 to 0.37 - 1.8 - 17.0 to 13.5 0.81 0.75 2.4 ± 0.3 - 0.42 - 1.01 to 0.17 - 16.3 - 39.0 to 6.4 0.36 0.26 
RWT  0.48 ± 0.10 0.47 ± 0.10 - 0.010 - 0.086 to 0.067 - 2.1 - 18.8 to 14.7 0.93 0.90 0.42 ± 0.10 - 0.060 - 0.221 to 0.102 - 13.7 - 47.8 to 20.6 0.56 0.45 
Vcf (circ/s) 0.85 ± 0.19 0.91 ± 0.18 0.052 - 0.188 to 0.293 6.2 - 19.7 to 32.1 0.75 0.64 0.92 ± 0.22 0.062 - 0.350 to 0.474 6.5 - 36.5 to 49.4 0.51 0.35 
Vcfc (circ/s) 1.02 ± 0.17 1.11 ± 0.19 0.054 - 0.235 to 0.342 5.3 - 20.6 to 31.1 0.55 0.37 1.12 ± 0.20 0.067 - 0.383 to 0.517 6.2 - 35.5 to 47.9 0.28 0.07 
M
V
 
HR (/min) 42 ± 12 42 ± 13 - 0.4 - 8.2 to 7.5 - 0.5 - 18.0 to 17.1 0.92 0.89 43 ± 12 1.3 - 6.4 to 9.05 3.0 - 14.2 to 20.1 0.93 0.91 
MVCO (ms) 572 ± 78 595 ± 82 21.2 - 53.5 to 95.9 3.6 - 8.7 to 15.9 0.83 0.77 586 ± 81 18.7 - 63.6 to 101.1 3.2 - 10.9 to 17.4 0.81 0.74 
IMP 0.28 ± 0.17 0.36 ± 0.12 0.095 - 0.134 to 0.323 36.2 - 43.5 to 115.8 0.47 0.29 0.35 ± 0.12 0.090 - 0.155 to 0.336 39.4 - 59.8 to 138.7 0.53 0.37 
A
oV
 
HR (/min) 43 ± 12 
 
42 ± 11 - 0.1 - 9.1 to 8.9 0.2 - 19.0 to 19.3 0.93 0.90 
LVPEP (ms) 74 ± 32 81 ± 28 12.7 - 22.0 to 47.3 19.0 - 27.6 to 65.6 0.77 0.68 
LVET (ms) 460 ± 61 437 ± 51 - 26.0 - 92.2 to 40.1 - 5.7 - 20.3 to 8.9 0.76 0.67 
LVPEP/LVET 0.17 ± 0.09 0.19 ± 0.09 0.039 - 0.056 to 0.134 24.6 - 27.9 to 77.1 0.80 0.72 
EMS (ms) 534 ± 55 517 ± 52 - 13.3 - 75.1 to 48.4 - 2.4 - 14.3 to 9.5 0.81 0.73 
LV: Left ventricle. MV: Mitral valve. AoV: Aortic valve.  
CMMsx: Conventional M-mode short-axis. AMMsx: Anatomical M-mode short-axis. AMMlx: Anatomical M-mode long-axis.  
SD: Standard deviation. LA: Limits of agreement. ρc: Concordance correlation coefficient. CL: Confidence limit. 
HR: Heart Rate. IVSd: Interventricular septal thickness at end-diastole. LVIDd: Left ventricular internal diameter at end-diastole. LVPWd: Left ventricular free 
wall thickness at end-diastole. IVSs: Interventricular septal thickness at peak systole. LVIDs: Left ventricular internal diameter at peak systole. LVPWs: Left 
ventricular free wall thickness at peak systole. LV FS: Left ventricular fractional shortening. LV mass: Left ventricular mass. MWT: Mean left ventricular wall 
thickness at end-diastole. RWT: Relative left ventricular wall thickness at end-diastole. Vcf: Mean velocity of circumferential fiber shortening. Vcfc: Rate-
corrected mean velocity of circumferential fiber shortening. MVCO: Mitral valve closure-to-opening interval. IMP: Index of myocardial performance. LVPEP: 
Left ventricular pre-ejection period. LVET: Left ventricular ejection time. EMS: Duration of electromechanical systole.  
 
Table B: Reliability of echocardiographic variables of LV size and function measured by CMM and AMM. 
 
CV%: Coefficient of variation (%). BSI: Absolute value below which the difference between two measurements will lie with 95% probability (following the 
British Standards Institution). For remainder of the key see Table 2. 
 
  CMMsx AMMsx AMMlx 
 Intraobserver Interobserver Intraobserver Interobserver Intraobserver Interobserver 
Variable CV% BSI CV% BSI CV% BSI CV% BSI CV% BSI CV% BSI 
LV
 
HR (/min) 1.3 1.3 0.8 0.8 1.9 1.9 1.9 1.9 0.8 0.8 2.9 2.9 
IVSd (cm) 1.9 0.18 2.3 0.22 1.0 0.10 1.6 0.15 9.3 0.70 14.5 1.16 
LVIDd (cm) 1.4 0.46 1.6 0.53 1.6 0.54 2.2 0.75 2.8 0.93 2.2 0.74 
LVPWd (cm) 3.1 0.24 7.6 0.59 3.1 0.23 6.1 0.46 8.4 0.63 4.9 0.35 
IVSs (cm) 2.1 0.29 5.3 0.73 3.9 0.53 4.8 0.64 6.4 0.68 4.0 0.43 
LVIDs (cm) 2.1 0.42 4.7 0.96 1.8 0.36 4.0 0.80 3.1 0.64 4.3 0.92 
LVPWs (cm) 2.0 0.26 1.6 0.21 2.6 0.35 1.2 0.16 5.9 0.75 3.7 0.47 
LV FS (%) 3.6 4.1 5.7 6.2 1.1 1.3 5.1 5.7 4.6 4.9 9.3 9.5 
LV mass (g) 2.5 418.1 4.5 778.7 2.5 406.0 4.4 736.1 6.5 919.1 9.0 1299.8 
MWT (cm) 1.3 0.11 4.0 0.34 1.1 0.09 2.8 0.23 6.4 0.49 7.7 0.59 
RWT 1.9 0.028 5.7 0.083 2.0 0.028 4.8 0.069 9.7 0.125 9.0 0.115 
Vcf (circ/s) 2.3  0.055  5.3  0.122  3.6  0.094  3.3 0.081 3.0  0.076  8.6 0.200 
Vcfc (circ/s) 2.4  0.074  5.5  0.162  3.7  0.123  3.1 0.099 3.1  0.100  7.8 0.236 
M
V
 HR (/min) 2.1 2.1 2.8 2.8 1.2 1.2 1.1 1.1 1.9 1.9 3.2 3.2 
MVCO (ms) 1.3 22.5 2.5 41.2 3.7 62.8 4.2 70.4 3.8 65.4 6.4 107 
IMP 11.3  0.079 16.9  0.124  12.6  0.135  16.7 0.168 22.6  0.243  24.7 0.249 
A
oV
 
HR (/min) 0.9  0.9  3.6  3.8  
 
0.3  0.3  1.6 1.6 
LVPEP (ms) 7.9  14.9  11.0  18.7  10.8  24.1  11.7 25.5 
LVET (ms) 2.6  35.2  3.6  47.1  3.0  36.4  2.9 35.4 
LVPEP/LVET 6.5  0.026  12.6  0.046  13.0  0.066  14.3 0.071 
EMS (ms) 3.0  45.5  3.2  46.8  1.9  20.1  1.5 22.3 
  
 
Figure I: Anatomical M-mode image of the left ventricle (LV), reconstructed from a digitally stored 2D cineloop 
recording obtained from a right parasternal long-axis view. Notice that the AMM cursor line (green) is 
positioned at the chordal level, parallel to the MV annulus and does not originate from the top of the 2D imaging 
sector. A chordal trace is visible within the LV lumen (arrowheads). The tip of the septal mitral valve leaflet 
appears in the LVlumen as it crosses the cursor line during early diastole (arrows). IVS, interventricular septum; 
LVPW, LV free wall. 
 
Figure II: Anatomical M-mode images of mitral valve motion, reconstructed from a digitally stored 2D cineloop 
recording obtained from a right parasternal long-axis view. The AMM cursor line (green) is placed across the 
MV leaflets. Depending on the position of the cursor line, the time of mitral valve closure (Figure IIA, MVC) or 
mitral valve opening (Figure IIB, MVO) can be identified. The ability to track mitral valve motion by AMM 
greatly facilitates measuring the mitral valve closure-to-opening time compared to conventional M-mode 
imaging.  
 
